| Bristol Myers Squibb (BMY) |
United States |
$138.567B |
10.67 |
| Amgen (AMGN) |
United States |
$138.060B |
14.99 |
| CSL (CSLLY) |
Australia |
$97.403B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$77.731B |
11.19 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$63.808B |
24.40 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$56.803B |
31.70 |
| Illumina (ILMN) |
United States |
$47.641B |
55.40 |
| Biogen (BIIB) |
United States |
$44.329B |
7.59 |
| Seattle Genetics (SGEN) |
United States |
$34.961B |
0.00 |
| Moderna (MRNA) |
United States |
$29.176B |
0.00 |
| BeiGene (BGNE) |
Cayman Islands |
$28.695B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$27.206B |
11.34 |
| Genmab (GMAB) |
Denmark |
$24.097B |
15.20 |
| Genmab (GNMSF) |
Denmark |
$22.720B |
5.23 |
| BioNTech SE (BNTX) |
Germany |
$21.289B |
0.00 |
| Immunomedics (IMMU) |
United States |
$20.239B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.827B |
0.00 |
| Incyte (INCY) |
United States |
$19.821B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$16.862B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$16.440B |
38.47 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$15.730B |
71.14 |
| Exact Sciences (EXAS) |
United States |
$15.515B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.372B |
104.28 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$12.687B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$11.916B |
30.24 |
| MyoKardia (MYOK) |
United States |
$11.767B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$11.181B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$10.243B |
70.28 |
| Guardant Health (GH) |
United States |
$10.042B |
0.00 |
| Repligen (RGEN) |
United States |
$8.966B |
142.31 |
| Mirati Therapeutics (MRTX) |
United States |
$8.847B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$8.418B |
30.46 |
| Ascendis Pharma (ASND) |
Denmark |
$8.374B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$7.707B |
238.76 |
| Exelixis (EXEL) |
United States |
$7.178B |
26.10 |
| Adaptive Biotechnologies (ADPT) |
United States |
$7.019B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$6.997B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$6.719B |
0.00 |
| Novavax (NVAX) |
United States |
$6.559B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.832B |
15.93 |
| Blueprint Medicines (BPMC) |
United States |
$5.656B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$5.572B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$5.233B |
20.73 |
| Vir Biotechnology (VIR) |
United States |
$5.011B |
0.00 |
| NeoGenomics (NEO) |
United States |
$4.770B |
1439.67 |
| Denali Therapeutics (DNLI) |
United States |
$4.679B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$4.665B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.479B |
26.59 |
| Amicus Therapeutics (FOLD) |
United States |
$4.443B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$4.239B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$4.224B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$3.940B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$3.860B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.790B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$3.715B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.688B |
48.33 |
| Insmed (INSM) |
United States |
$3.684B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.632B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$3.321B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$2.938B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$2.876B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$2.724B |
57.10 |
| Seres Therapeutics (MCRB) |
United States |
$2.597B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.434B |
0.00 |
| I-Mab (IMAB) |
China |
$2.319B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$2.097B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$2.096B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$2.054B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.014B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.985B |
0.00 |
| Viela Bio (VIE) |
United States |
$1.831B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$1.817B |
20.35 |
| Intra-Cellular Therapies (ITCI) |
United States |
$1.773B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.689B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$1.687B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.597B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.589B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.571B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.565B |
52.89 |
| Intellia Therapeutics (NTLA) |
United States |
$1.534B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.522B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.483B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$1.364B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.358B |
0.00 |
| Alcobra (ARCT) |
United States |
$1.349B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.297B |
7.56 |
| Mesoblast (MESO) |
Australia |
$1.279B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.238B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.223B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.161B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$1.148B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.136B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.124B |
0.00 |
| Retrophin (RTRX) |
United States |
$1.114B |
0.00 |
| Compugen (CGEN) |
Israel |
$1.082B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.073B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.042B |
0.00 |
| Athenex (ATNX) |
United States |
$1.022B |
0.00 |
| NantKwest (NK) |
United States |
$0.995B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.995B |
0.00 |
| Heska (HSKA) |
United States |
$0.992B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$0.984B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$0.967B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.937B |
0.00 |
| Vericel (VCEL) |
United States |
$0.936B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.881B |
0.00 |
| Intrexon (PGEN) |
United States |
$0.863B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.843B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.836B |
0.00 |
| Codexis (CDXS) |
United States |
$0.832B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.821B |
0.00 |
| Alector (ALEC) |
United States |
$0.816B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.804B |
0.00 |
| Agenus (AGEN) |
United States |
$0.803B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.766B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.743B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.724B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.685B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.678B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.670B |
15.29 |
| VBI Vaccines (VBIV) |
United States |
$0.666B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.657B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.656B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
43.13 |
| Celldex Therapeutics (CLDX) |
United States |
$0.617B |
0.00 |
| Geron (GERN) |
United States |
$0.599B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.590B |
5.16 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.580B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.580B |
0.00 |
| IVERIC Bio (ISEE) |
United States |
$0.571B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.551B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.548B |
23.94 |
| Clovis Oncology (CLVS) |
United States |
$0.529B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.520B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.519B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.506B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.486B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.477B |
0.00 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.470B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.463B |
0.00 |
| MannKind (MNKD) |
United States |
$0.458B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.454B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.453B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.451B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.440B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.435B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.428B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.428B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.424B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.424B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.395B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.390B |
0.00 |
| Trevena (TRVN) |
United States |
$0.387B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.384B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.379B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.372B |
26.36 |
| Athersys (ATHX) |
United States |
$0.369B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.367B |
8.66 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.364B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.357B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.357B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.354B |
16.92 |
| Cardiff Oncology (CRDF) |
United States |
$0.353B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.350B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.340B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.335B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.329B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.325B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.317B |
0.00 |
| NextCure (NXTC) |
United States |
$0.313B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.308B |
0.00 |
| Osmotica Pharmaceuticals (OSMT) |
United States |
$0.308B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.273B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.271B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.267B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.264B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.248B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.243B |
0.00 |
| XOMA (XOMA) |
United States |
$0.234B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.232B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.231B |
0.00 |
| Verastem (VSTM) |
United States |
$0.222B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.218B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.213B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.196B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.190B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.185B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.183B |
0.00 |
| Cerecor (CERC) |
United States |
$0.181B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.175B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.175B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.174B |
0.00 |
| Exicure (XCUR) |
United States |
$0.173B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.172B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.169B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.168B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.167B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.162B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.158B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.157B |
7.35 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.156B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.149B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.144B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.142B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.141B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.141B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.132B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.132B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.130B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.125B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.122B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.121B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.119B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.118B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.114B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.114B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.112B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.112B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.111B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.109B |
5.55 |
| Unum Therapeutics (COGT) |
United States |
$0.109B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.108B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.103B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.102B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.101B |
0.00 |
| PhaseBio Pharaceuticals (PHAS) |
United States |
$0.101B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.100B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.098B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.087B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.086B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.082B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.080B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.079B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.074B |
71.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.072B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.069B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.069B |
0.00 |
| Curis (CRIS) |
United States |
$0.068B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.068B |
0.00 |
| Adocia (ADOCY) |
France |
$0.067B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.066B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.066B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.066B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.064B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.063B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.063B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.060B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.060B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.057B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.053B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.051B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.048B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.047B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.044B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.043B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.042B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.041B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.041B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.040B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.039B |
0.00 |
| Apricus Biosciences (SEEL) |
United States |
$0.039B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.037B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.034B |
0.00 |
| OvaScience (MLND) |
United States |
$0.034B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.032B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.031B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.030B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.029B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.027B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.027B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.025B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.024B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.023B |
0.00 |
| Celsion (CLSN) |
United States |
$0.023B |
0.00 |
| Spherix (AIKI) |
United States |
$0.020B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.020B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.019B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.019B |
0.00 |
| MYOS RENS Technology (MYOS) |
United States |
$0.016B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.014B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.011B |
0.00 |
| Benitec Biopharma (BNTC) |
Australia |
$0.003B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.002B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
